Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check4 days agoChange DetectedThe page’s UI/display revision has been updated from v3.5.2 to v3.5.3, indicating a minor release change rather than an update to the study record content.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Hartung et al. 'Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis' (Neurol Ther, 2026; online ahead of print). Updated page revision to v3.4.3 (replacing v3.4.2).SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 added; previous notice about government funding lapse (v3.4.1) removed. These changes affect only site maintenance and operate-status messaging, not trial data, eligibility, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedFunding-status notice appears at the top of the page and the site revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.